Archived Seminar: Design and Optimization of CAR T cells and their Application to Glioblastoma
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Encouraging clinical experience with chimeric antigen receptor (CAR) T cells supports the notion that even immune privileged sites such as the brain may be amenable to CAR therapy. In the context of hematologic B-cell malignancies, CD19-CARs have been shown to accumulate in the cerebrospinal fluid (CSF) and reduce the incidence of metastatic disease in the central nervous system. However, brain tumors pose significant challenges for CAR T cell therapy, including heterogeneous antigen expression, immunosuppressive networks in the tumor microenvironment that limit CAR T cell function and persistence, and suboptimal T cell trafficking to the tumor site. This presentation will describe our clinical experience with CAR T cells for glioblastoma (GBM), one of the most common and aggressive primary malignant brain tumors, and our efforts to overcome therapeutic challenges.
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
General ItemVirtual Public Lecture: How Vaccines Train the Immune System in Ways No One Expected
April 15, 2021, 5:30 p.m. | Christine Stabell Benn, M.D., Ph.D., D.M.Sc. | Maury Strauss Distinguished Public Lecture
General ItemVirtual Seminar: Aerobic Fitness and Susceptibility for Metabolic Dysfunction
April 16, 2021, 11 a.m. | John Thyfault, Ph.D. | Pioneers in Biomedical Research Seminar Series
General ItemVirtual Lecture: Mechanism of Treatment Resistance in Human Glioblastoma
April 16, 2021, 1 p.m. | W.K. Alfred Yung, M.D. | Timothy A. Johnson Medical Scholar Seminar Series
General ItemVirtual Seminar: Multi-channel MEG Measurements with a Wearable OPM System
April 23, 2021, 11 a.m. | Elena Boto, Ph.D. | Pioneers in Biomedical Research Seminar Series
General ItemVirtual Seminar: Control of TGF-beta Signaling and Epithelial-Mesenchymal Transition
April 30, 2021, 11 a.m. | Rik Derynck, Ph.D. | Pioneers in Biomedical Research Seminar Series
Christine Brown, Ph.D.
Professor in the Department of Hematology and Hematopoietic Cell Transplantation; Heritage Provider Network Professor in Immunotherapy; and Deputy Director of the T Cell Therapeutics Research Laboratory, at City of Hope